URSY.NEWS / Ars Technica / 31 Oct 2026
The FDA wants to pull its approval of a drug. It’s not so easy.
Publisher access: Free. This source-level label does not guarantee access to every article.
The regulator says Tavneos was approved on the basis of manipulated study data. Should patients still have access to it?
Read the full story at arstechnica.com
URSY.NEWS archives headline details from the publisher's own feed and links you to the publisher. The article itself lives — and stays — with Ars Technica.
Time supplied by the publisher feed. First observed by URSY: